TO READ THIS STORY - you must have a paid subscription to Technology Review OR you can purchase special archive reading credits here. Choose from these great offers below.

I'm a paid subscriber please
log me in

I want to purchase this article for
only 99¢
(requires login)

I want to purchase five articles for
only $3.99
(requires login)

I want to buy
1 Year TOTAL Access for
only $24.95
(requires login)

Please note: Click here if you are currently a Technology Review print or digital subscriber and do not have access to this article.

Click here if you are an MIT alum and do not have access to this article.

November 2003

Stopping Pain

Insights into the neuroscience behind pain are spawning a new generation of drugs designed to short-circuit the body's pain signals without side effects.

By Ken Garber

On April 29, 1997, the supermarket tabloid the National Examiner ran this headline on its cover: "Miracle Pain Cure: Deadly Snail Venom." The garbled story within contained a kernel of truth. Doctors in fact were injecting a drug derived from the venom of a marine snail into patients suffering from the worst kinds of pain imaginable.

Select from the choices above
to read the entire article.

Customer Service

Magazine Services

•	Subscription FAQ
•	Pay Your Bill
•	Renew Your Subscription
•	Change Your Address
•	Check Your Start/Expire Issue
•	Feedback
•	Buy a Back Issue
•	Permissions/Reprints
•	Cancel Your Subscription
•	Digital Subscription Customer Service